|Articles|May 15, 2002
- BioPharm International-05-01-2002
- Volume 15
- Issue 5
Travel Notes: Yes, Virginia, There is Biotech in the Commonwealth
Author(s)Lorna D. McLeod
by Lorna D. McLeod, BioPharm A network of resources and infrastructure facilitates the high-tech business actively courted and encouraged by the Commonwealth of Virginia.
Advertisement
Articles in this issue
over 23 years ago
Info+over 23 years ago
Analytical Advances: Strategies in Clarifying Mammalian Culturesover 23 years ago
Analytical Advances: Using Image Informatics - Focusing Proteomicsover 23 years ago
The Not-So-Sure Thingover 23 years ago
Washington Report: Vaccine Shortages put Spotlight on Productionover 23 years ago
Guest Editorial: Validation BingoNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
2
Industry Leaders Detail Transformational Strategies to Mainstream CAR-T Care
3
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
4
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
5
